» Articles » PMID: 38462732

Intrinsic and Extrinsic Factors Causing Hyperplasia of the Prostate

Overview
Journal Int J Urol
Specialty Urology
Date 2024 Mar 11
PMID 38462732
Authors
Affiliations
Soon will be listed here.
Abstract

Prostatic hyperplasia is very common in elderly men and is a typical disease that reduces quality of life. Histologically, hyperplasia of the prostate gland causes obstruction at the bladder outlet, resulting in symptoms such as a weak urine stream. Various factors have been considered to cause histological enlargement of the prostate, but the underlying cause is still unknown. The factors that cause prostate hyperplasia can be broadly classified into intrinsic and extrinsic ones. Extrinsic factors include things that we directly come into contact with such as bacteria and food. On the other hand, intrinsic factors are those that cause changes in functions originally provided in the body due to some cause, including extrinsic factors, such as chronic inflammation and an imbalance of sex hormones. A large number of reports have been made to date regarding the etiology of prostatic hyperplasia, although they have not yet clarified the fundamental cause(s). The various factors currently known should be outlined for future research. Should it be possible to prevent this highly prevalent prostatic hyperplasia which is mainly cause of dcreasing quality of life, there is no doubt that it would be a huge contribution to humanity.

Citing Articles

Efficacy and safety of prostatic urethral lift according to preoperative urinary retention and prostate volume: A Japanese real-world multicenter data.

Anan G, Minami H, Fujishima Y, Kaga K Int J Urol. 2024; 32(2):190-197.

PMID: 39501555 PMC: 11803185. DOI: 10.1111/iju.15621.

References
1.
Roberts R, Jacobson D, Rhodes T, Klee G, Leiber M, Jacobsen S . Serum sex hormones and measures of benign prostatic hyperplasia. Prostate. 2004; 61(2):124-31. DOI: 10.1002/pros.20080. View

2.
Habenicht U, Schwarz K, Neumann F, El Etreby M . Induction of estrogen-related hyperplastic changes in the prostate of the cynomolgus monkey (Macaca fascicularis) by androstenedione and its antagonization by the aromatase inhibitor 1-methyl-androsta-1,4-diene-3,17-dione. Prostate. 1987; 11(4):313-26. DOI: 10.1002/pros.2990110404. View

3.
An J, Song Y, Kim S, Kong H, Kim K . Alteration of Gut Microbes in Benign Prostatic Hyperplasia Model and Finasteride Treatment Model. Int J Mol Sci. 2023; 24(6). PMC: 10057928. DOI: 10.3390/ijms24065904. View

4.
Marks L, Mazer N, Mostaghel E, Hess D, Dorey F, Epstein J . Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial. JAMA. 2006; 296(19):2351-61. DOI: 10.1001/jama.296.19.2351. View

5.
Lagiou P, Wuu J, Trichopoulou A, Hsieh C, Adami H, Trichopoulos D . Diet and benign prostatic hyperplasia: a study in Greece. Urology. 1999; 54(2):284-90. DOI: 10.1016/s0090-4295(99)00096-5. View